Gene Test May Refine Chemo Choices - Top-Institutions - MDSpire

Gene Test May Refine Chemo Choices

Real-world study suggests genomic testing could help laboratories support more personalized chemotherapy decisions in early breast cancer

  • July 13, 2026

  • 3 min

Share

Top Institutions in Pathology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology

  • #2

    Foundation Medicine
    Foundation Medicine

    Cambridge, MA

    Key Differentiators

    • Oncology

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Oncology

  • #4

    University of Pennsylvania Health System
    University of Pennsylvania Health System

    Philadelphia, PA

    Key Differentiators

    • Oncology

  • #5

    Moffitt Cancer Center
    Moffitt Cancer Center

    Tampa, FL

    Key Differentiators

    • Oncology

Original Source(s)

Gene Test May Refine Chemo Choices

  • July 13, 2026

Related Content

CTE-type tau filaments in Alzheimer’s disease with co-morbid LATE-NC

Can AI Outpace Infectious Diseases?

Leading experts discuss the opportunities, challenges, and future applications of AI in infectious disease testing

Histopathological biomarkers of immunotherapy outcome in advanced colorectal cancer: a multicentre retrospective study